drugset / Trial / NCT00131820
Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
Phase 4
Completed
100742 enrolled
International Vaccine Institute
GlaxoSmithKline · collabHue Preventive Medicine Center, Vietnam · collabNational Institute of Hygiene and Epidemiology, Vietnam · collabUniversity of Western Ontario, Canada · collabWellcome Trust · collab
RandomizedSingle-groupDouble-blindPrevention
Summary
This study is part of International Vaccine Institutes (IVI)'s typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The primary objectives of the study are to evaluate the logistic feasibility of a mass typhoid fever immunization campaign program targeting school age children in Hue City, Vietnam and to assess the knowledge, attitudes, beliefs, and practices of parents and healthcare providers in Hue City regarding typhoid fever prevention and treatment.
Timeline
- Start
- 2001-12
- Primary completion
- 2007-01
- Completion
- 2007-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hepatitis A | Vaccine | — | — |
| Subject | Typhoid Vi vaccine | Vaccine | — | — |